Purchase this article with an account.
F. Zakka, S. Pujari, M. Shaikh, E. Yuksel, D. Hinkle, C. S. Foster; Long-Term Outcomes of Selective Laser Trabeculoplasty in Patients with Uveitis. Invest. Ophthalmol. Vis. Sci. 2009;50(13):159.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To assess the effectiveness of selective laser trabeculoplasty (SLT) in lowering intraocular pressure (IOP) in patients with uveitis.
A Retrospective chart review was conducted of 61 patients (69 eyes) with uveitis and IOP elevation at the Massachusetts Eye Research and Surgery Institution. Outcomes of SLT, including IOP and number of uveitis flare-ups, were assessed at 1, 3, 6 and 12 months following the procedure.
Among the 69 eyes treated with SLT, 40 eyes (58%), 4 eyes (5.8%), and 25(36.2%) had anterior uveitis, intermediate uveitis, and posterior or panuveitis respectively. The total number of eyes that were followed-up at 1, 3, 6, and 12 months was 56, 54, 54 and 26 respectively. The mean intra-ocular pressure reduction from baseline at 1,3,6 and 12 months was 15.8%, 20.3%, 21.3% and 23.0% respectively, which was significant. The mean number of uveitis flare-ups following SLT at 1, 3, 6, and 12 months was 0.36, 0.25, 0.35, 0.58 respectively. Six eyes required other glaucoma surgery to control IOP.
SLT significantly lowered IOP at all follow-up visits. This procedure can be used effectively as an adjunctive therapy for patients with uveitic glaucoma.
This PDF is available to Subscribers Only